Medicines360 Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEDICINES360, and what generic alternatives to MEDICINES360 drugs are available?
MEDICINES360 has one approved drug.
There are four US patents protecting MEDICINES360 drugs.
There are thirty-three patent family members on MEDICINES360 drugs in nineteen countries and nine supplementary protection certificates in nine countries.
Summary for Medicines360
| International Patents: | 33 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Medicines360
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicines360 | LILETTA | levonorgestrel | SYSTEM;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | 11,571,328 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Medicines360 | LILETTA | levonorgestrel | SYSTEM;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Medicines360 | LILETTA | levonorgestrel | SYSTEM;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | 10,028,858 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Medicines360 | LILETTA | levonorgestrel | SYSTEM;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | 12,004,992 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Medicines360 Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 104023681 | ⤷ Subscribe |
| Chile | 2014000080 | ⤷ Subscribe |
| Japan | 2014523780 | ⤷ Subscribe |
| European Patent Office | 2731562 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Medicines360 Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1453521 | 300814 | Netherlands | ⤷ Subscribe | PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
| 1453521 | 39/2015 | Austria | ⤷ Subscribe | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
| 1453521 | 122015000093 | Germany | ⤷ Subscribe | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
| 1453521 | C201630040 | Spain | ⤷ Subscribe | PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
